#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma
Click to read this study in the Journal of Clinical Oncology.
Tag: plasma EBV DNA
#VisualAbstract: Induction chemotherapy with concurrent chemoradiotherapy may improve survival in intermediate-risk pediatric patients with nasopharyngeal carcinoma
Click to read this study in the European Journal of Cancer.
#VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Camrelizumab plus gemcitabine and cisplatin improves progression-free survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Click to read the study in The Lancet Oncology.
#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma
Click to read the study in Clinical Cancer Research.